Clinical performance evaluation of VIDAS® dengue NS1 Ag, VIDAS® Anti-DENGUE IgM and VIDAS® Anti-DENGUE IgG assays in endemic population

被引：0
|
作者：
Tessonneau, M. [1 ]
Foussadier, A. [1 ]
Dromenq, L. [1 ]
Brossault, L. [1 ]
机构：
[1] BioMerieux, Marcilly Et Dracy, France
来源：
TROPICAL MEDICINE & INTERNATIONAL HEALTH | 2021年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
396
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [21] Apropos "viral load in patients infected with dengue is modulated by the presence of anti-dengue IgM antibodies"
    Arya, Subhash C.
    Nirmala, Agarwal
    JOURNAL OF CLINICAL VIROLOGY, 2013, 58 (02) : 497 - 497
  • [22] Anti-dengue Vaccines: From Development to Clinical Trials
    Pinheiro-Michelsen, Josilene Ramos
    Oliveira Souza, Rayane da Silva
    Rocha Santana, Itana Vivian
    da Silva, Patricia de Souza
    Mendez, Erick Carvalho
    Luiz, Wilson Barros
    Amorim, Jaime Henrique
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [23] Clinical evaluation of dengue RNA, NS1, and IgM for diagnosis of dengue in Southern China
    Chen, Xinliang
    Chen, Rui
    Gu, Wenshen
    He, Jian
    Cai, Weipeng
    Li, Jiajia
    Duan, Chaohui
    Yan, Haiyan
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (01) : 28 - 34
  • [24] COMPLEMENT-FIXATION BLOCKING ACTIVITY OF ANTI-DENGUE IGM ANTIBODY
    SCOTT, RM
    RUSSELL, PK
    JOURNAL OF IMMUNOLOGY, 1972, 109 (04): : 875 - &
  • [25] Serological investigation of the prevalence of anti-dengue IgM and IgG antibodies in Attapeu Province, South Laos
    Peyerl-Hoffmann, G
    Schwöbel, B
    Jordan, S
    Vamisaveth, V
    Phetsouvanh, R
    Christophel, EM
    Phompida, S
    Sonnenburg, FV
    Jelinek, T
    CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (02) : 181 - 184
  • [26] Comparison of a dipstick dot-ELISA with commercial assays for anti-dengue virus IgM antibodies
    Abhyankar, A. V.
    Dash, P. K.
    Saxena, P.
    Bhargava, R.
    Parida, M. M.
    Jana, A. M.
    Sahni, A. K.
    Rao, P. V. L.
    VIRAL IMMUNOLOGY, 2006, 19 (04) : 630 - 636
  • [27] Comparison of Two Commercial ELISA Kits for the Detection of Anti-Dengue IgM for Routine Dengue Diagnosis in Laos
    Lu, Yixiao
    Sengvilaipaseuth, Onanong
    Chanthongthip, Anisone
    Phonemixay, Ooyanong
    Vongsouvath, Manivanh
    Phouminh, Phonelavanh
    Blacksell, Stuart D.
    Newton, Paul N.
    Dubot-Peres, Audrey
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2019, 4 (03)
  • [28] Anti-dengue NS1 antibody induces heme oxygenase-1 gene expression in endothelial cells
    Rahayu, P.
    Naidu, S.
    Rachman, A.
    Immenschuh, S.
    Santoso, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 129 - 129
  • [29] Optimization of the Cutoff Value for a Commercial Anti-Dengue Virus IgG Immunoassay
    Marrero-Santos, Karla M.
    Beltran, Manuela
    Carrion-Lebron, Jessica
    Sanchez-Vegas, Carolina
    Hamer, Davidson H.
    Barnett, Elizabeth D.
    Santiago, Luis M.
    Hunsperger, Elizabeth A.
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (03) : 358 - 362
  • [30] Development of an Anti-Zika and Anti-Dengue IgM ELISA Assay: Evaluation of Cross Reactivity and Validation
    Cerutti, Helena
    Tesi, Giulia
    Soldatini, Claudia
    Bandini, Tommaso
    Castria, Marinunzia
    Brogi, Alessandra
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (11)
12345